Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGrau Vorster, Marta
dc.contributor.authorLopez Montañes, Maria
dc.contributor.authorCanto Puig, Ester
dc.contributor.authorVives Armengol, Joaquim
dc.contributor.authorOliver-Vila, Irene
dc.contributor.authorBarba Suñol, Pere
dc.contributor.authorRudilla Salvador, Francesc
dc.date.accessioned2021-09-08T07:38:53Z
dc.date.available2021-09-08T07:38:53Z
dc.date.issued2020-02-25
dc.identifier.citationGrau-Vorster M, López-Montañés M, Cantó E, Vives J, Oliver-Vila I, Barba P, et al. Characterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy. Front Immunol. 2020 Feb 25;11:271.
dc.identifier.issn1664-3224
dc.identifier.urihttp://hdl.handle.net/11351/6278
dc.descriptionImmunoteràpia adoptiva; Citotoxicitat; Limfòcits T específics del virus (VST)
dc.description.sponsorshipWork in our laboratory was supported by the Spanish Cell Therapy Network (TerCel, file No. RD16/0011/0028), and carried out as part of AdvanceCat with the support of ACCIÓ (Catalonia Trade & Investment; Catalan government) under the Catalonian ERDF operational program (European Regional Development Fund) 2014-2020. Our laboratory was certified by the Catalan government as a Consolidated Research Group (ref. 2017SGR719).
dc.language.isoeng
dc.publisherFrontiers Media
dc.relation.ispartofseriesFrontiers in Immunology;11
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectInfeccions per citomegalovirus
dc.subjectCèl·lules T
dc.subjectImmunoteràpia
dc.subject.meshImmunotherapy, Adoptive
dc.subject.meshT-Lymphocytes, Cytotoxic
dc.subject.meshCytomegalovirus Infections
dc.titleCharacterization of a Cytomegalovirus-Specific T Lymphocyte Product Obtained Through a Rapid and Scalable Production Process for Use in Adoptive Immunotherapy
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3389/fimmu.2020.00271
dc.subject.decsinfecciones por Citomegalovirus
dc.subject.decsinmunoterapia adoptiva
dc.subject.decslinfocitos T citotóxicos
dc.relation.publishversionhttps://doi.org/10.3389/fimmu.2020.00271
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Grau-Vorster M, López-Montañés M, Cantó E, Rudilla F] Cell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain. Grup de Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Vives J] Cell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain. Grup de Medicina Transfusional, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. Grup d’Enginyeria tissular musculoesquelètica, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Oliver-Vila I] Cell Therapy Service, Banc de Sang i Teixits, Barcelona, Spain. [Barba P] Servei d’Hematologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain
dc.identifier.pmid32161589
dc.identifier.wos000524779300001
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PE2013-2016/RD16%2F0011%2F0028
dc.relation.projectidinfo:eu-repo/grantAgreement/ES/PERIS2016-2020/2017SGR719
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple